The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
On 15 January 2025, the US Food and Drug Administration (FDA) announced that it will revoke the color additive authorization ...
Despite the seemingly restrictive nature of the FDA's proposed ruling, I remain highly optimistic about the resilience and ...
Hosted on MSN2d
FDA Proposes Nicotine Cap To Help Curb Cigarette AddictionA rather historic U.S. Food and Drug Administration (FDA) proposal aims to make cigarettes and other tobacco products far ...
Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris ...
Altria (NYSE: MO) owns the Marlboro brand, which has a roughly 41% market share in North America. That's huge and highlights the company's dominance in this geographic region. But the downside ...
Altria is one of the largest cigarette makers in North America. Although Altria has a solid position atop this geographic region, the North American cigarette market is witnessing steady declines ...
Altria Group Inc. Altria Group (MO ... saw success recently with the Food and Drug Administration approval of the schizophrenia drug Cobenify. This puts the company in a good position to continue ...
Altria Group, Inc. MO stock is currently trading at a forward 12-month price-to-earnings (P/E) ratio of 9.85, representing a 16.9% discount compared to the Zacks Tobacco industry’s average of 11.85.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback